Ellevest, Inc. Jounce Therapeutics, Inc. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	SELL	$6.01 - $8.54 $90 - $128	-15 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$5.04 - $8.73 $95 - $165	-19 Reduced 55.88%	15 $0
Q4 2020 Feb 04, 2021	BUY	$6.37 - $10.33 $216 - $351	34 New	34 $0
Q2 2020 Jul 06, 2020	SELL	$4.17 - $7.58 $842 - $1,531	-202 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$2.91 - $8.7 $87 - $261	30 Added 17.44%	202 $1,000
Q4 2019 Feb 05, 2020	BUY	$2.81 - $9.21 $483 - $1,584	172 New	172 $2,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.